Skip to main content
Journal cover image

Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial.

Publication ,  Journal Article
Douglas, PS; Hahn, RT; Pibarot, P; Weissman, NJ; Stewart, WJ; Xu, K; Wang, Z; Lerakis, S; Siegel, R; Thompson, C; Gopal, D; Keane, MG ...
Published in: J Am Soc Echocardiogr
February 2015

BACKGROUND: Inoperable aortic stenosis may be treated with either transcatheter aortic valve replacement (TAVR) or medical management (MM) with or without balloon aortic valvuloplasty (BAV). The aim of this study was to compare the long-term echocardiographic findings among TAVR, MM, and BAV in patients with severe, inoperable aortic stenosis. METHODS: A total of 358 inoperable patients in the Placement of Aortic Transcatheter Valves trial were randomized to MM or TAVR. Echocardiograms obtained at baseline, 30 days, and 1, 2, and 3 years were analyzed by a central core laboratory. RESULTS: At baseline, TAVR and MM were similar, with more frequent Society of Thoracic Surgeons score > 10 (51.7% vs 65.0%, P = .03) and larger end-systolic volumes (54.5 ± 29.3 vs 69.1 ± 48.0 mL, P = .03) in MM. By 30 days after TAVR, mean aortic valve gradient had decreased (from 43.8 ± 14.7 to 10.0 ± 4.3 mm Hg, P < .001), ejection fraction had increased (from 53.2 ± 12.4% to 56.7 ± 10.0%, P < .001), and left ventricular (LV) mass index had decreased (from 144.7 ± 36.1 to 140.0 ± 37.9 gm/m(2), P < .05). After 1 year, aortic valve gradients and area were unchanged, while LV mass index had decreased by another 16 gm/m(2) (to 124 gm/m(2)). By 30 days after BAV, mean aortic valve gradient had decreased from 43.4 ± 15.0 to 31.9 ± 11.1 mm Hg, while ejection fraction and LV mass index were unchanged; gradient reverted to baseline at 1 year. No changes in gradients or mass were seen in MM patients. CONCLUSIONS: TAVR results in immediate and sustained relief in pressure overload and improved LV systolic function, with continued regression of hypertrophy over 3 years. Poor clinical results with BAV are explained by the modest and transient reductions in pressure overload with BAV, which were not accompanied by improved LV function or remodeling. TAVR is the preferred treatment in eligible inoperable patients (ClinicalTrials.gov identifier NCT00530894).

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Soc Echocardiogr

DOI

EISSN

1097-6795

Publication Date

February 2015

Volume

28

Issue

2

Start / End Page

210-7.e1-9

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Transcatheter Aortic Valve Replacement
  • Survival Rate
  • Statistics, Nonparametric
  • Severity of Illness Index
  • Risk Assessment
  • Patient Selection
  • Male
  • Longitudinal Studies
  • Kaplan-Meier Estimate
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Douglas, P. S., Hahn, R. T., Pibarot, P., Weissman, N. J., Stewart, W. J., Xu, K., … Leon, M. B. (2015). Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial. J Am Soc Echocardiogr, 28(2), 210-7.e1-9. https://doi.org/10.1016/j.echo.2014.10.009
Douglas, Pamela S., Rebecca T. Hahn, Philippe Pibarot, Neil J. Weissman, William J. Stewart, Ke Xu, Zuyue Wang, et al. “Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial.J Am Soc Echocardiogr 28, no. 2 (February 2015): 210-7.e1-9. https://doi.org/10.1016/j.echo.2014.10.009.
Douglas, Pamela S., et al. “Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial.J Am Soc Echocardiogr, vol. 28, no. 2, Feb. 2015, pp. 210-7.e1-9. Pubmed, doi:10.1016/j.echo.2014.10.009.
Douglas PS, Hahn RT, Pibarot P, Weissman NJ, Stewart WJ, Xu K, Wang Z, Lerakis S, Siegel R, Thompson C, Gopal D, Keane MG, Svensson LG, Tuzcu EM, Smith CR, Leon MB. Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial. J Am Soc Echocardiogr. 2015 Feb;28(2):210-7.e1-9.
Journal cover image

Published In

J Am Soc Echocardiogr

DOI

EISSN

1097-6795

Publication Date

February 2015

Volume

28

Issue

2

Start / End Page

210-7.e1-9

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Transcatheter Aortic Valve Replacement
  • Survival Rate
  • Statistics, Nonparametric
  • Severity of Illness Index
  • Risk Assessment
  • Patient Selection
  • Male
  • Longitudinal Studies
  • Kaplan-Meier Estimate